Recent Developments and Hot Topics Panel Discussion
A session from FDLI’s Introduction to Tobacco Law and Regulation
Recorded October 8, 2025
Introduction to Tobacco and Nicotine Law and Regulation: Recent Developments and Hot Topics Panel Discussion
Access to recordings of virtual introductory courses is limited to one year from the date of purchase as we update programs annually.
Amy K. Madl, President, Senior Principal Health Scientist, Public Policy, Valeo Sciences
Brittani Cushman, Senior Vice President, General Counsel, and Secretary, Turning Point Brands, Inc.
Rachael Schmidt, Regulatory Compliance Consultant, ALINC Consulting LLC
Sydney Hiller, Senior Scientist, Sanova
This session was recorded as part of FDLI’s Virtual Introduction to Tobacco Law and Regulation Course in October 2025.
Dr. AMY MADL is President and Senior Principal Health Scientist with Valeo Sciences, a scientific consulting firm which provides integrative, multi-disciplinary, and fit-for-purpose scientific solutions to complex issues related to human health. Dr. Madl is board certified in toxicology, a Diplomate of the American Board of Toxicology (DABT), and has focused her academic and consulting experience in the field of inhalation toxicology. She has 25 years of experience in the sampling and analysis, toxicology, exposure, and risk assessment of airborne chemicals. Dr. Madl also holds a research position with the University of California, Davis, where her research interests have focused on the toxicological effects of inhaled nanoparticles and electronic nicotine delivery system (ENDS) products. She has served as co-investigator on multidisciplinary research teams for inhalation research studies funded by the NIEHS, University of California Toxic Substances Research & Teaching Program, and Tobacco Related Disease Research Program. Dr. Madl has led interdisciplinary research programs with the mission to integrate material physicochemistry, toxicology and hazard evaluation, and exposure science to characterize human health risk and public health impacts. Dr. Madl’s academic and consulting research of nicotine products has involved physicochemistry, toxicology, consumer exposures, pharmacokinetic and topography studies, and human health risk assessments. Dr. Madl has published over 125 abstracts, book chapters, and peer-reviewed papers on various exposure, toxicology, and risk-related topics, including issues involving chemical exposures in occupational, environmental, medical device, and consumer product scenarios.
RACHAEL TRIMPERT SCHMIDT (retired CAPT, USPHS) brings over a decade of experience in regulatory and compliance solutions within the tobacco and nicotine industry. With a distinguished tenure at the FDA, serving as the Assistant Director of Laboratory Compliance & Coordination of the CTP, she spearheaded crucial initiatives to enforce the FSPTCA of 2009. During her tenure at FDA, CAPT Schmidt played a pivotal role in establishing and coordinating FDA tobacco regulatory laboratories, ensuring rigorous adherence to regulatory standards. Her leadership was instrumental in developing and executing comprehensive tobacco product testing programs, encompassing pre-market application reviews, post-market compliance assessments, adverse event evaluations, and the development of tobacco product standards. Schmidt’s expertise extends to fostering collaboration with national and international stakeholders to harmonize tobacco enforcement and policy efforts.
Get Access
$149
-
+$100 for nonmembers
Virtual Learning FAQ
Related Content
